Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Efemp1em1/Cya
Common Name:
Efemp1-KO
Product ID:
S-KO-05188
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Efemp1-KO
Strain ID
KOCMP-216616-Efemp1-B6J-VA
Gene Name
Efemp1
Product ID
S-KO-05188
Gene Alias
--
Background
C57BL/6JCya
NCBI ID
216616
Modification
Conventional knockout
Chromosome
11
Phenotype
MGI:1339998
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Efemp1em1/Cya mice (Catalog S-KO-05188) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000020759
NCBI RefSeq
NM_146015
Target Region
Exon 3~4
Size of Effective Region
~1.4 kb
Detailed Document
Click here to download >>
Overview of Gene Research
EFEMP1, also known as epidermal growth factor-containing fibulin-like extracellular matrix protein 1, is involved in multiple biological processes. It is likely to participate in extracellular matrix-related functions and may be associated with pathways influencing cell-matrix interactions, angiogenesis, and tissue homeostasis. Its importance spans across various biological systems and is crucial for normal physiological functions [1-10].

EFEMP1 has been linked to numerous disease conditions. In bladder cancer, the METTL1-m7G-EGFR/EFEMP1 axis promotes cancer development, with METTL1 regulating the translation of EFEMP1 through tRNA modification [1]. Haploinsufficiency of EFEMP1 due to nonsense-mediated decay can cause a Marfan-like hereditary connective tissue disorder, presenting symptoms such as severe kyphoscoliosis and joint hypermobility [2]. Rare EFEMP1 coding variants can lead to familial juvenile-onset open-angle glaucoma through protein aggregation and retention mechanisms [3,9]. In age-related macular degeneration, EFEMP1 overexpression contributes to neovascularization, making it a potential biomarker for choroidal neovascularization in AMD [4]. In zebrafish, efemp1 regulates light-dependent ocular growth, and in myopia patients, EFEMP1 may be involved in regulating choroidal thickness [5,6]. In osteosarcoma, serum EFEMP1 levels can be used to distinguish patients from healthy controls and as an indicator for lung metastasis [7]. In direct inguinal hernia, EFEMP1 is downregulated and regulates elastin homeostasis and fibroblast mobility [8]. Also, EFEMP1 has been implicated as a determinant of neurodegeneration in proteomic analyses [10].

In conclusion, EFEMP1 is essential for maintaining normal physiological functions in multiple biological systems. Model-based research, especially in understanding its role in diseases like cancer, connective tissue disorders, glaucoma, age-related macular degeneration, myopia, osteosarcoma, inguinal hernia, and neurodegeneration, has provided valuable insights. These studies on EFEMP1 contribute to a better understanding of disease mechanisms and may potentially lead to the development of new diagnostic and therapeutic strategies.

References:

1. Ying, Xiaoling, Liu, Bixia, Yuan, Zusen, Luo, Junhang, Ji, Weidong. . METTL1-m7 G-EGFR/EFEMP1 axis promotes the bladder cancer development. In Clinical and translational medicine, 11, e675. doi:10.1002/ctm2.675. https://pubmed.ncbi.nlm.nih.gov/34936728/

2. Forghani, Irman, Lang, Steven H, Rodier, Matthew J, Bademci, Guney, Tekin, Mustafa. 2024. EFEMP1 haploinsufficiency causes a Marfan-like hereditary connective tissue disorder. In American journal of medical genetics. Part A, 194, e63556. doi:10.1002/ajmg.a.63556. https://pubmed.ncbi.nlm.nih.gov/38348595/

3. Collantes, Edward Ryan A, Delfin, Manuel S, Fan, Baojian, Rong, Shisong, Wiggs, Janey L. 2021. EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma. In Human mutation, 43, 240-252. doi:10.1002/humu.24320. https://pubmed.ncbi.nlm.nih.gov/34923728/

4. Cheng, Lu, Chen, Chong, Guo, Wenke, Yu, Fudong, Xu, Xun. 2021. EFEMP1 Overexpression Contributes to Neovascularization in Age-Related Macular Degeneration. In Frontiers in pharmacology, 11, 547436. doi:10.3389/fphar.2020.547436. https://pubmed.ncbi.nlm.nih.gov/33584252/

5. Xie, Jiaheng, Bui, Bang V, Goodbourn, Patrick T, Jusuf, Patricia R. 2024. EFEMP1 contributes to light-dependent ocular growth in zebrafish. In Biology open, 13, . doi:10.1242/bio.061741. https://pubmed.ncbi.nlm.nih.gov/39607017/

6. Shi, Wen-Qing, Wan, Ting, Li, Bing, Li, Tao, Zhou, Xiao-Dong. 2023. EFEMP1 is a potential biomarker of choroid thickness change in myopia. In Frontiers in neuroscience, 17, 1144421. doi:10.3389/fnins.2023.1144421. https://pubmed.ncbi.nlm.nih.gov/36891459/

7. Wang, Zhuo, Kang, Jihui, Lian, Jiayan, Ma, Huisi, Lin, Zhongwei. 2020. EFEMP1 as a Potential Biomarker for Diagnosis and Prognosis of Osteosarcoma. In BioMed research international, 2020, 5264265. doi:10.1155/2020/5264265. https://pubmed.ncbi.nlm.nih.gov/32280689/

8. Peng, Xiaohui, Guo, Zhongwu, Zhang, Yinlong, Sun, Baichen, Zhang, Qi. 2020. EFEMP1 in Direct Inguinal Hernia: correlation with TIMP3 and Regulation Toward Elastin Homoeostasis as Well as Fibroblast Mobility. In Journal of investigative surgery : the official journal of the Academy of Surgical Research, 35, 203-211. doi:10.1080/08941939.2020.1811812. https://pubmed.ncbi.nlm.nih.gov/33131351/

9. Collantes, Edward Ryan A, Delfin, Manuel S, Fan, Baojian, Rong, Shisong, Wiggs, Janey L. 2022. EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma. In Human mutation, 43, 1343. doi:10.1002/humu.24395. https://pubmed.ncbi.nlm.nih.gov/35490425/

10. Duggan, Michael R, Yang, Zhijian, Cui, Yuhan, Davatzikos, Christos, Walker, Keenan A. 2024. Proteomic analyses reveal plasma EFEMP1 and CXCL12 as biomarkers and determinants of neurodegeneration. In Alzheimer's & dementia : the journal of the Alzheimer's Association, 20, 6486-6505. doi:10.1002/alz.14142. https://pubmed.ncbi.nlm.nih.gov/39129354/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest